Robotic Prescription Dispensing System

ESSENTIAL CHARACTERISTICS ROBOTIC PRESCRIPTION DISPENSING SYSTEM The Naval Medical Logistics Command intends to negotiate on a sole source basis (IAW FAR 13.501) with ScriptPro USA, Inc, 5828 Reeds Rd, Shawnee Mission, KS 66202, as the only responsible source that can provide an expansion and upgrade to the proprietary ScriptPro robotic medication dispensing system currently installed at the facility. The requirement is for an expansion and upgrade to the existing robotic prescription dispensing system. The activity requires a robotic prescription dispensing system. The robotic prescription dispensing systems shall be able to automatically select a prescription vial of the proper size, fill the vial with the proper medication and print and apply the correct prescription label. The system shall use bar codes to confirm correct drug product and strength. Vials shall be filled directly from drug dispensing cells to prevent cross-contamination. Medication dispensing cells shall be able to be calibrated on-site to fit any size and shape pill, capsule or tablet without the need to be shipped offsite prior to being used with a new medication. The vial shall be collated, uncapped for the pharmacist to perform a final verification. The system must be compatible with proprietary ScriptPro products. The electrical requirement for the systems is 120 VAC, 60 Hz, single phase. The upgrade to the two installed ScriptPro robotic prescription dispensing systems shall allow the robots to have collating capability to separate prescriptions by name or type as well as upgrade the current system to allow more than one prescription to be counted simultaneously for increased output. One robot shall be upgraded to have a six slot collating center while the second robot shall be upgraded to have a twelve slot collating center. The systems shall be compliant with the Food and Drug Administration (FDA) requirements to market and deliver medical products for use in the United States of America, even should delivery be requested outside of the United States. The claims made for the product shall comply with the regulations of the FDA with respect to products for marketing and delivery of a medical product for use in the United States of America, even should delivery be requested outside of the United States. Regulatory Requirements: The system and all of the components, shall be compliant with the Food and Drug Administration (FDA) requirements to market and deliver medical products for use in the United States of America, even should delivery be requested outside of the United States. The claims made for the product shall comply with the regulations of the FDA with respect to products for marketing and delivery of a medical product for use in the United States of America, even should delivery be requested outside of the United States. This acquisition is being conducted under simplified acquisition procedures FAR 13.501 under the authority of the test program for commercial items (section 4202 of the Clinger-Cohen Act of 1996). There are not set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 454390. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data, sufficient to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Capability statements shall be submitted by email only as a MS Word or Adobe PDF attachment to erin.cotter@med.navy.mil. No phone calls accepted.